Inflammatory Diseases

The purpose of this licence is to identify potential new medicines for treating inflammatory diseases such as rheumatoid arthritis (RA), asthma, rhinitis (eg hay fever) and chronic respiratory disease (eg COPD).

Date: Wed May 24 14:08:19 BST 2006